€1.60
0.00% yesterday
Xetra, Nov 25, 05:36 pm CET
ISIN
DE0006044001
Symbol
MAK
Index

MATERNUS-Kliniken Stock price

€1.60
-0.16 9.09% 1M
-0.19 10.61% 6M
-1.26 44.06% YTD
-1.18 42.45% 1Y
-3.20 66.67% 3Y
-0.25 13.51% 5Y
+1.27 387.80% 10Y
Xetra, Closing price Mon, Nov 25 2024
+0.00 0.00%
ISIN
DE0006044001
Symbol
MAK
Index
Sector

Key metrics

Market capitalization €33.55m
Enterprise Value €218.15m
P/E (TTM) P/E ratio negative
EV/FCF (TTM) EV/FCF 43.11
EV/Sales (TTM) EV/Sales 2.01
P/S ratio (TTM) P/S ratio 0.31
P/B ratio (TTM) P/B ratio negative
Revenue growth (TTM) Revenue growth 6.08%
Revenue (TTM) Revenue €108.71m
EBIT (operating result TTM) EBIT €2.37m
Free Cash Flow (TTM) Free Cash Flow €5.06m
EPS (TTM) EPS €-0.33
Show more

Is MATERNUS-Kliniken a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,883 stocks worldwide.

MATERNUS-Kliniken Stock Analysis

Unlock Scores for Free

Analyst Opinions

1 Analyst has issued a forecast MATERNUS-Kliniken:

1x Hold
100%

Analyst Opinions

1 Analyst has issued a forecast MATERNUS-Kliniken:

Hold
100%

Financial data from MATERNUS-Kliniken

Income Statement P&L | Balance Sheet | Cash Flow


TTM Annually
Jun '24
+/-
%
109 109
6% 6%
100%
- Direct Costs 100 100
1% 1%
92%
8.30 8.30
432% 432%
8%
- Selling and Administrative Expenses - -
- Research and Development Expense - -
-
-
12 12
530% 530%
11%
- Depreciation and Amortization 10 10
1% 1%
9%
EBIT (Operating Income) EBIT 2.37 2.37
118% 118%
2%
Net Profit -6.88 -6.88
63% 63%
-6%

In millions EUR.

Don't miss a Thing! We will send you all news about MATERNUS-Kliniken directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

MATERNUS-Kliniken Stock News

EQS
about 2 months ago
Weitere positive Effekte auf die Ergebnisentwicklung im Konzern hatte das in 2023 initiierte Kostensenkungsprogramm. Kosteneinsparungen ergaben sich im Energiebereich aus einer zum Jahresende 2023 verhandelten Festpreisvereinbarung, darüber hinaus durch den nur noch geringen Einsatz von Fremdarbe...
EQS
3 months ago
Der Vorstand erwartet für die Ergebniskennzahl EBITDA (Ergebnis vor Abschreibungen, Zinsen und Steuern) im Jahr 2024 nunmehr 10 bis 12 Mio.€ (bisher: moderat über dem Vorjahresniveau von 4,5 Mio. €) bei einer EBITDA-Marge (EBITDA im Verhältnis zum Konzernumsatz) von 9 bis 10 Prozent (bisher: mode...
More MATERNUS-Kliniken News

Company Profile

Maternus-Kliniken AG engages in the operation of senior housing facilities, nursing homes, and rehabilitation centers. It operates through the following segments: Rehabilitation, Senior Retirement Homes and Nursing Care Facilities, and Maternus AG. The Rehabilitation segment comprises follow-up treatment and rehabilitation measures in the indication areas orthopedics, behavioral orthopedics, cardiology, internal medicine, metabolic disorders, and neurology. The Senior Retirement Homes and Nursing Care Facilities segment specializes in full-station services care, short-term care, and assisted living. The Maternus AG segment provides primarily intersegmentary services. The company was founded in 1877 and is headquartered in Berlin, Germany.

Head office Germany
CEO Mario Ruano-Wohlers
Employees 1,989
Founded 1877
Website www.maternus.de

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today